Elevance Health (ELV) FY2015 results: revenue $79.2 billion, up 7.2% on the year
Elevance Health, Inc. (ELV) reported revenue of $79.2 billion for fiscal 2015, the year ended 31 December 2015, up 7.2% on the year before. Net income was $2.6 billion, down 0.4%, and diluted earnings per share $9.38. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2016.
Revenue
$79.2 billion
+7.2% on the year
FY2008FY2015
Operating margin
6.0%
6.0% a year earlier
FY2008FY2015
Net income
$2.6 billion
-0.4% on the year
FY2008FY2015
Diluted EPS
$9.38
+4.3% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
79,156
73,874
71,024
+7.2%
Selling, general and administrative
12,535
11,748
9,953
+6.7%
Operating income
4,753
4,418
4,001
+7.6%
Operating margin
6.0%
6.0%
5.6%
Interest expense
653
601
603
+8.7%
Pre-tax income
4,631
4,368
3,840
+6.0%
Income tax
2,071
1,808
1,206
+14.5%
Effective tax rate
44.7%
41.4%
31.4%
Net income
2,560
2,570
2,490
-0.4%
Net margin
3.2%
3.5%
3.5%
Diluted EPS
$9.38
$8.99
$8.20
+4.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
4,212
3,369
3,052
+25.0%
Capital expenditure
638
715
646
-10.7%
Free cash flow
3,574
2,655
2,406
+34.6%
Free cash flow margin
4.5%
3.6%
3.4%
Cash from investing
-1,152
-975
-2,234
Cash from financing
-3,093
-1,822
-1,718
Depreciation and amortisation
336
327
353
+2.6%
Share-based compensation
148
169
146
-12.3%
Buybacks
1,516
2,999
1,620
-49.5%
Dividends paid
657
481
448
+36.6%
Dividend per share
$2.50
$1.75
$1.50
+42.9%
Diluted shares, weighted
273m
286m
304m
-4.5%
Shares outstanding at period end
261m
268m
293m
-2.6%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
23,044
24,251
24,765
-5.0%
Debt
15,864
15,044
14,492
+5.5%
Other liabilities
22,809
22,381
20,318
+1.9%
Total liabilities and equity
61,718
61,676
59,574
+0.1%
Fixed assets
2,020
1,944
1,802
+3.9%
Goodwill
17,562
17,082
16,917
+2.8%
Intangible assets
8,158
7,958
8,441
+2.5%
Investments
17,478
17,972
17,488
-2.7%
Cash and equivalents
2,114
2,152
1,582
-1.8%
Other assets
14,386
14,568
13,345
-1.3%
Total assets
61,718
61,676
59,574
+0.1%
10-K for the year ended 31 December 2015, filed 19 February 2016: the filing.